Middleby Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $3.4B+7.6% YoYTTM through 4 Jul 2026
Net Income -$471.3M-210.0% YoYTTM through 4 Jul 2026
Free Cash Flow $482.1MTTM through 4 Jul 2026
Margins
| Current | |
|---|---|
| Gross Margin | 38.5% |
| EBITDA Margin | 20.1% |
| Operating Margin | 15.9% |
| Net Margin | -13.9% |
Returns
-21.3%ROE
-8.8%ROA
-11.7%ROIC
Balance Sheet Health
Debt / Equity0.79x
Current Ratio1.96x
Net Debt$1.7B
Cash & Equivalents$159.2M
Quality Metrics
Altman Z-Score3.20
Piotroski F-Score5 / 9
FCF Margin14.2%
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2026: $3.2B
Diluted EPS-$9.19TTMFY2026: $-5.32
Dividend
No dividend
Capital Allocation
R&D Spend$58.8M
Capex Intensity1.4%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.